These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2999656)

  • 41. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors.
    Jacques D; Cadieux A; Dumont Y; Quirion R
    Eur J Pharmacol; 1995 May; 278(1):R3-5. PubMed ID: 7664808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of methods for measurement of steroid hormone receptors.
    Armitage EK; Kohl HH; Alonso KB; Brownlee NR
    Ann Clin Lab Sci; 1981; 11(1):69-74. PubMed ID: 7212631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel glutamic acid derived cholecystokinin receptor ligands.
    Freidinger RM; Whitter WL; Gould NP; Holloway MK; Chang RS; Lotti VJ
    J Med Chem; 1990 Feb; 33(2):591-5. PubMed ID: 2299627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The study of neurohypophyseal hormone receptors by ligand binding.
    Wheatley M; Howl J; Davies AR; Parslow RA
    Biochem Soc Trans; 1994 Feb; 22(1):113-8. PubMed ID: 8206202
    [No Abstract]   [Full Text] [Related]  

  • 46. Assay for the cholecystokinin receptor on pancreatic acini.
    Jensen RT; Gardner JD
    Methods Enzymol; 1985; 109():64-9. PubMed ID: 2985933
    [No Abstract]   [Full Text] [Related]  

  • 47. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
    Toth G; Russell KC; Landis G; Kramer TH; Fang L; Knapp R; Davis P; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1992 Jun; 35(13):2384-91. PubMed ID: 1320122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Competitive binding assay for estradiol receptor using immobilized antibody.
    Fishman J; Fishman JH
    J Clin Endocrinol Metab; 1974 Sep; 39(3):603-6. PubMed ID: 4369882
    [No Abstract]   [Full Text] [Related]  

  • 49. A mathematical model on the analysis of a one-ligand, one-binding group system when an unknown amount of endogenous ligand is present.
    Leung YK; Wong LK
    J Recept Res; 1989; 9(2):127-42. PubMed ID: 2545873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacological basis of receptor binding.
    Schütz W
    Wien Klin Wochenschr; 1991; 103(15):438-42. PubMed ID: 1656614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high-affinity, radioiodinatable neuropeptide FF analogue incorporating a photolabile p-(4-hydroxybenzoyl)phenylalanine.
    Bray L; Moulédous L; Tafani JA; Germanier M; Zajac JM
    Anal Biochem; 2014 May; 453():50-4. PubMed ID: 24613258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Saturation analysis of ligand binding using a centrifugation procedure.
    Layer RT
    Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.7. PubMed ID: 18428533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of angiotensin II receptors in the anterior pituitary gland.
    Hauger RL; Aguilera G; Baukal AJ; Catt KJ
    Mol Cell Endocrinol; 1982 Feb; 25(2):203-12. PubMed ID: 6276251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo quantification of asialoglycoprotein receptor.
    Kudo M; Vera DR; Stadalnik RC
    Methods Enzymol; 1994; 247():373-82. PubMed ID: 7898365
    [No Abstract]   [Full Text] [Related]  

  • 55. Saturation assays of radioligand binding to receptors and their allosteric modulatory sites.
    Basile A
    Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.6. PubMed ID: 18428532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
    J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro isolated tissue functional muscarinic receptor assays.
    Pulido-Rios MT; Steinfeld T; Armstrong S; Watson N; Choppin A; Eglen R; Hegde SS
    Curr Protoc Pharmacol; 2010 Mar; Chapter 4():Unit 4.15. PubMed ID: 22294371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of positron emission tomography ligands for NPY Y5 receptors in the brain.
    Takahashi H; Haga Y; Shibata T; Nonoshita K; Sakamoto T; Moriya M; Ohe T; Chiba M; Mitobe Y; Kitazawa H; Iwaasa H; Ishihara A; Ishii Y; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5436-9. PubMed ID: 19679469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine.
    Walther G; Daniel H; Bechtel WD; Brandt K
    Arzneimittelforschung; 1990 Apr; 40(4):440-6. PubMed ID: 1972625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostanoid receptor assays.
    Chen J; Woodward DF; Coleman RA; Jones RL; Lydford SJ
    Curr Protoc Pharmacol; 2001 Nov; Chapter 4():Unit4.18. PubMed ID: 21959759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.